Related Experiment Video
Updated: Jan 14, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
Systematic Mapping of Worldwide Research on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and
Melissa Lou Silva1, Renan Prado2
1Department of Radiology, Liver Imaging Group, University of California San Diego, San Diego, USA.
Background And Aims:
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease worldwide, affecting up to 38% of adults and nearly two-thirds of patients with type 2 diabetes, of whom one-third develop metabolic dysfunction-associated steatohepatitis (MASH). Although only a minority progress to cirrhosis or hepatocellular carcinoma, the absolute burden is substantial and continues to rise, particularly in Asia and Latin America. While population-level disparities are well documented, little is known about inequities within the scientific literature itself. We aimed to systematically map global MASLD/MASH research to identify patterns in productivity, geographic distribution, authorship, and disparities.
Methods:
We analyzed publications from 1980 to 2024 in the Web of Science Core Collection (extraction May 15, 2025). After excluding meeting abstracts, 36,268 records were included. Using the Bibliometrix R package, we evaluated annual production, country and institutional contributions, authorship patterns, and journal sources. Disparity analyses focused on the 1000 most cited articles, assessing country contributions, first-author sex, and journal representation.
Results:
Analysis of the 1000 most cited MASLD/MASH publications revealed rapid growth since the early 2000s, peaking at over 60 papers annually between 2010 and 2020, with an apparent recent decline due to citation lag. The United States dominated both output and citations, far surpassing other countries. Hepatology, Journal of Hepatology, and Gastroenterology accounted for most influential publications. Leading contributors included two authors, with 50 articles each. Striking gender disparities emerged: only 3% of top 100 papers had female first authors. Overall, research remains concentrated geographically, institutionally, and by author, with persistent inequities in authorship representation.
Conclusions:
MASLD/MASH research is highly concentrated by geography, journals, and authorship, with pronounced gender disparities. Expanding inclusivity and fostering international collaborations are essential to advance this field.
More Related Videos
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):